4.7 Article

Shikonin Binds and Represses PPARγ Activity by Releasing Coactivators and Modulating Histone Methylation Codes

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Kaempferol antagonizes adipogenesis by repressing histone H3K4 methylation at PPAR? target genes

Ui-Hyun Park et al.

Summary: In this study, we investigated the underlying mechanism of kaempferol in inhibiting adipogenesis. Our findings suggest that kaempferol regulates the expression of adipogenic genes by modulating histone modifications and directly binding to PPARγ. The study highlights the potential of kaempferol as an epigenetic drug for the treatment of obesity-related diseases.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Medicine, Research & Experimental

Novel shikonin derivatives suppress cell proliferation, migration and induce apoptosis in human triple-negative breast cancer cells via regulating PDK1/PDHC axis

Qingqing Chen et al.

Summary: This study evaluated the anti-tumor activities of semi-synthesized shikonin (SK) derivatives against human breast cancer cells. The findings showed that these derivatives exhibited strong inhibition of cell proliferation and migration, and induced cell apoptosis through regulating apoptosis and glucose metabolism pathways.

LIFE SCIENCES (2022)

Review Gastroenterology & Hepatology

Peroxisome proliferator-activated receptor gamma as a therapeutic target for hepatocellular carcinoma: Experimental and clinical scenarios

Swati Katoch et al.

Summary: Hepatocellular carcinoma (HCC) is the most common type of liver cancer, with viral hepatitis being a significant risk factor. Peroxisome-proliferator-activated receptor gamma (PPAR gamma) plays a crucial role in the pathogenesis of HCC. Synthetic agonists of PPAR gamma have shown potential in suppressing HCC, but they may also have severe side effects. Natural PPAR gamma agonists can be an alternative option for HCC treatment.

WORLD JOURNAL OF GASTROENTEROLOGY (2022)

Review Chemistry, Medicinal

Capsaicin for Weight Control: Exercise in a Pill (or Just Another Fad)?

Arpad Szallasi

Summary: The medical management of obesity is in high demand. Capsaicin, a potential weight control agent, has been critically evaluated for its efficacy and safety, and although it is not a magic weight loss pill, emerging evidence suggests it may have a positive impact on gut microbiota.

PHARMACEUTICALS (2022)

Article Oncology

Shikonin derivatives for cancer prevention and therapy

Joelle C. Boulos et al.

CANCER LETTERS (2019)

Article Chemistry, Medicinal

Piperine inhibits adipocyte differentiation via dynamic regulation of histone modifications

Ui-Hyun Park et al.

PHYTOTHERAPY RESEARCH (2019)

Review Biochemistry & Molecular Biology

Writing, erasing and reading histone lysine methylations

Kwangbeom Hyun et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2017)

Article Biochemistry & Molecular Biology

ASXL2 promotes proliferation of breast cancer cells by linking ERα to histone methylation

U-H Park et al.

ONCOGENE (2016)

Review Biochemistry & Molecular Biology

The interplay of histone modifications - writers that read

Tianyi Zhang et al.

EMBO REPORTS (2015)

Article Food Science & Technology

Shikonin protects against obesity through the modulation of adipogenesis, lipogenesis, and β-oxidation in vivo

So Young Gwon et al.

JOURNAL OF FUNCTIONAL FOODS (2015)

Article Agriculture, Multidisciplinary

Piperine, a Component of Black Pepper, Inhibits Adipogenesis by Antagonizing PPARγ Activity in 3T3-L1 Cells

Ui-Hyun Park et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2012)

Article Multidisciplinary Sciences

Sequences Sufficient for Programming Imprinted Germline DNA Methylation Defined

Yoon Jung Park et al.

PLOS ONE (2012)

Article Chemistry, Medicinal

Shikonin Inhibits Fat Accumulation in 3T3-L1 Adipocytes

Haeyong Lee et al.

PHYTOTHERAPY RESEARCH (2010)

Review Biochemistry & Molecular Biology

The many faces of PPARγ

M Lehrke et al.

Article Pharmacology & Pharmacy

Second-generation thiazolidinediones and hepatotoxicity

TR Marcy et al.

ANNALS OF PHARMACOTHERAPY (2004)